Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In-Jin Jang

Showing results (71-80 of 292) with videos related to

Pageof 30
Sort By:
British Journal of Clinical Pharmacology|April 17, 2016
Population pharmacokinetic analysis to recommend the optimal dose of udenafil in patients with mild and moderate hepatic impairmentAnhye Kim, Jongtae Lee, Donghoon Shin, et al.
Therapeutic Drug Monitoring|July 9, 2014
Limited sampling strategy of partial area under the concentration-time curves to estimate midazolam systemic clearance for cytochrome P450 3A phenotypingJoanna C Masters, Denise M Harano, Howard E Greenberg, et al.
Pharmaceutics|February 25, 2023
Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy SubjectsJungJin Oh, Eunsol Yang, In-Jin Jang, et al.
Journal of Proteome Research|December 22, 2009
Verification of biomarkers for diabetic retinopathy by multiple reaction monitoringKyunggon Kim, Sang Jin Kim, Hyeong Gon Yu, et al.
Drug Design, Development and Therapy|October 23, 2014
Effect of renal function on the pharmacokinetics of fimasartan: a single-dose, open-label, Phase I studySeokuee Kim, Jongtae Lee, Donghoon Shin, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2022
A Phase 1 Study To Evaluate Safety and Pharmacokinetics following Administration of Single and Multiple Doses of the Antistaphylococcal Lysin LSVT-1701 in Healthy Adult SubjectsMary Beth Wire, Soo Youn Jun, In-Jin Jang, et al.
Journal of Cardiovascular Pharmacology|December 2, 2011
Pharmacokinetics and pharmacodynamics of oral tolvaptan administered in 15- to 60-mg single doses to healthy Korean menSojeong Yi, Hyewon Jeon, Seo Hyun Yoon, et al.
Metabolomics : Official Journal of the Metabolomic Society|March 5, 2019
Ursodeoxycholic acid exerts hepatoprotective effects by regulating amino acid, flavonoid, and fatty acid metabolic pathwaysDa Jung Kim, Hyewon Chung, Sang Chun Ji, et al.
Basic & Clinical Pharmacology & Toxicology|August 24, 2017
Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing NomogramSeonghae Yoon, Kyoung Ryun Park, SeungHwan Lee, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 8, 2014
Pharmacokinetic-pharmacodynamic relationships of macitentan, a new endothelin receptor antagonist, after multiple dosing in healthy Korean subjectsLi Young Ahn, Sung Eun Kim, SoJeong Yi, et al.
Pageof 30

Showing results (71-80 of 292) with videos related to

Sort By:
Pageof 30
British Journal of Clinical Pharmacology|April 17, 2016
Population pharmacokinetic analysis to recommend the optimal dose of udenafil in patients with mild and moderate hepatic impairmentAnhye Kim, Jongtae Lee, Donghoon Shin, et al.
Therapeutic Drug Monitoring|July 9, 2014
Limited sampling strategy of partial area under the concentration-time curves to estimate midazolam systemic clearance for cytochrome P450 3A phenotypingJoanna C Masters, Denise M Harano, Howard E Greenberg, et al.
Pharmaceutics|February 25, 2023
Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy SubjectsJungJin Oh, Eunsol Yang, In-Jin Jang, et al.
Journal of Proteome Research|December 22, 2009
Verification of biomarkers for diabetic retinopathy by multiple reaction monitoringKyunggon Kim, Sang Jin Kim, Hyeong Gon Yu, et al.
Drug Design, Development and Therapy|October 23, 2014
Effect of renal function on the pharmacokinetics of fimasartan: a single-dose, open-label, Phase I studySeokuee Kim, Jongtae Lee, Donghoon Shin, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2022
A Phase 1 Study To Evaluate Safety and Pharmacokinetics following Administration of Single and Multiple Doses of the Antistaphylococcal Lysin LSVT-1701 in Healthy Adult SubjectsMary Beth Wire, Soo Youn Jun, In-Jin Jang, et al.
Journal of Cardiovascular Pharmacology|December 2, 2011
Pharmacokinetics and pharmacodynamics of oral tolvaptan administered in 15- to 60-mg single doses to healthy Korean menSojeong Yi, Hyewon Jeon, Seo Hyun Yoon, et al.
Metabolomics : Official Journal of the Metabolomic Society|March 5, 2019
Ursodeoxycholic acid exerts hepatoprotective effects by regulating amino acid, flavonoid, and fatty acid metabolic pathwaysDa Jung Kim, Hyewon Chung, Sang Chun Ji, et al.
Basic & Clinical Pharmacology & Toxicology|August 24, 2017
Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing NomogramSeonghae Yoon, Kyoung Ryun Park, SeungHwan Lee, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 8, 2014
Pharmacokinetic-pharmacodynamic relationships of macitentan, a new endothelin receptor antagonist, after multiple dosing in healthy Korean subjectsLi Young Ahn, Sung Eun Kim, SoJeong Yi, et al.
Pageof 30